Výsledky vyhledávání

Akademický článek

Cell type and sex specific mitochondrial phenotypes in iPSC derived models of Alzheimer's disease.

Autor: Flannagan K; University of Kansas Alzheimer's Disease Research Center, University of Kansas Medical Center, Kansas City, KS, United States., Stopperan JA; University of Kansas Alzheimer's Disease Research Center, University of Kansas Medical Center, Kansas City, KS, United States., Hauger BM; University of Kansas Alzheimer's Disease Research Center, University of Kansas Medical Center, Kansas City, KS, United States., Troutwine BR; University of Kansas Alzheimer's Disease Research Center, University of Kansas Medical Center, Kansas City, KS, United States., Lysaker CR; University of Kansas Alzheimer's Disease Research Center, University of Kansas Medical Center, Kansas City, KS, United States.; Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS, United States., Strope TA; University of Kansas Alzheimer's Disease Research Center, University of Kansas Medical Center, Kansas City, KS, United States.; Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS, United States., Csikos Drummond V; University of Kansas Alzheimer's Disease Research Center, University of Kansas Medical Center, Kansas City, KS, United States.; Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS, United States., Gilmore CA; University of Kansas Alzheimer's Disease Research Center, University of Kansas Medical Center, Kansas City, KS, United States., Swerdlow NA; University of Kansas Alzheimer's Disease Research Center, University of Kansas Medical Center, Kansas City, KS, United States., Draper JM; Transgenic and Gene Targeting Facility, University of Kansas Medical Center, Kansas City, KS, United States., Gouvion CM; University of Kansas Alzheimer's Disease Research Center, University of Kansas Medical Center, Kansas City, KS, United States., Vivian JL; Transgenic and Gene Targeting Facility, University of Kansas Medical Center, Kansas City, KS, United States.; Department of Pediatrics, University of Kansas Missouri-Kansas City School of Medicine, Kansas City, KS, United States.; Institute for Reproduction and Perinatal Research, University of Kansas Medical Center, Kansas City, KS, United States.; Department of Pathology & Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, United States., Haeri M; University of Kansas Alzheimer's Disease Research Center, University of Kansas Medical Center, Kansas City, KS, United States.; Department of Pathology & Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, United States., Swerdlow RH; University of Kansas Alzheimer's Disease Research Center, University of Kansas Medical Center, Kansas City, KS, United States.; Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS, United States.; Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS, United States.; Department of Neurology, University of Kansas Medical Center, Kansas City, KS, United States., Wilkins HM; University of Kansas Alzheimer's Disease Research Center, University of Kansas Medical Center, Kansas City, KS, United States.; Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS, United States.; Department of Neurology, University of Kansas Medical Center, Kansas City, KS, United States.

Publikováno v: Frontiers in molecular neuroscience [Front Mol Neurosci] 2023 Aug 08; Vol. 16, pp. 1201015. Date of Electronic Publication: 2023 Aug 08 (Print Publication: 2023).

Zobrazit plný text záznamu

Akademický článek

Mitochondrial function and Aβ in Alzheimer's disease postmortem brain.

Autor: Troutwine BR; University of Kansas Alzheimer's Disease Center, Kansas City, KS, USA; Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA., Strope TA; University of Kansas Alzheimer's Disease Center, Kansas City, KS, USA; Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS, USA., Franczak E; Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS, USA., Lysaker CR; University of Kansas Alzheimer's Disease Center, Kansas City, KS, USA; Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS, USA., Hamid L; University of Kansas Alzheimer's Disease Center, Kansas City, KS, USA., Mansel C; University of Kansas Alzheimer's Disease Center, Kansas City, KS, USA., Stopperan JA; University of Kansas Alzheimer's Disease Center, Kansas City, KS, USA., Gouvion CM; University of Kansas Alzheimer's Disease Center, Kansas City, KS, USA; Department of Pathology & Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Haeri M; University of Kansas Alzheimer's Disease Center, Kansas City, KS, USA; Department of Pathology & Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Swerdlow RH; University of Kansas Alzheimer's Disease Center, Kansas City, KS, USA; Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA; Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS, USA; Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS, USA., Wilkins HM; University of Kansas Alzheimer's Disease Center, Kansas City, KS, USA; Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA; Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS, USA. Electronic address: hwilkins@kumc.edu.

Publikováno v: Neurobiology of disease [Neurobiol Dis] 2022 Sep; Vol. 171, pp. 105781. Date of Electronic Publication: 2022 Jun 03.

Zobrazit plný text záznamu

Akademický článek

Bioenergetic and inflammatory systemic phenotypes in Alzheimer's disease APOE ε4-carriers.

Autor: Wilkins HM; Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA.; University of Kansas Alzheimer's Disease Center, Kansas City, KS, USA.; Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS, USA., Wang X; Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA.; University of Kansas Alzheimer's Disease Center, Kansas City, KS, USA., Menta BW; University of Kansas Alzheimer's Disease Center, Kansas City, KS, USA.; Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS, USA., Koppel SJ; University of Kansas Alzheimer's Disease Center, Kansas City, KS, USA.; Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS, USA., Bothwell R; University of Kansas Alzheimer's Disease Center, Kansas City, KS, USA., Becker AM; University of Kansas Alzheimer's Disease Center, Kansas City, KS, USA., Anderson H; University of Kansas Alzheimer's Disease Center, Kansas City, KS, USA., Schwartz E; University of Kansas Alzheimer's Disease Center, Kansas City, KS, USA., Pei D; Department of Biostatistics and Data Science, University of Kansas Medical Center, Kansas City, KS, USA., Yellapu NK; Department of Biostatistics and Data Science, University of Kansas Medical Center, Kansas City, KS, USA., Chalise P; Department of Biostatistics and Data Science, University of Kansas Medical Center, Kansas City, KS, USA., Gouvion CM; University of Kansas Alzheimer's Disease Center, Kansas City, KS, USA.; Department of Pathology & Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Haeri M; University of Kansas Alzheimer's Disease Center, Kansas City, KS, USA.; Department of Pathology & Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS, USA., Burns JM; Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA.; University of Kansas Alzheimer's Disease Center, Kansas City, KS, USA., Swerdlow RH; Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA.; University of Kansas Alzheimer's Disease Center, Kansas City, KS, USA.; Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, KS, USA.; Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS, USA.

Publikováno v: Aging cell [Aging Cell] 2021 May; Vol. 20 (5), pp. e13356. Date of Electronic Publication: 2021 May 03.

Zobrazit plný text záznamu

Akademický článek

UBQLN2 mutation causing heterogeneous X-linked dominant neurodegeneration.

Autor: Fahed AC; Department of Genetics, Harvard Medical School, Boston, MA., McDonough B; Department of Genetics, Harvard Medical School, Boston, MA.; Cardiovascular Division and Howard Hughes Medical Institute, Brigham and Women's Hospital, Boston, MA., Gouvion CM; Departments of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS., Newell KL; Departments of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS., Dure LS; Departments of Neurology and Pediatrics, University of Alabama at Birmingham, Birmingham, AL., Bebin M; Departments of Neurology and Pediatrics, University of Alabama at Birmingham, Birmingham, AL., Bick AG; Department of Genetics, Harvard Medical School, Boston, MA., Seidman JG; Department of Genetics, Harvard Medical School, Boston, MA., Harter DH; Department of Neurology, School of Medicine & Health Sciences, The George Washington University, Washington, DC., Seidman CE; Department of Genetics, Harvard Medical School, Boston, MA.; Cardiovascular Division and Howard Hughes Medical Institute, Brigham and Women's Hospital, Boston, MA.

Publikováno v: Annals of neurology [Ann Neurol] 2014 May; Vol. 75 (5), pp. 793-798. Date of Electronic Publication: 2014 May 09.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání